are bodybuilders using glp 1 Eli Lilly's Retatrutide: Gym Goers Taking Knock Offs Before Launch Semaglutide & Tirzepatide: A Game

Adiponectin levels and sleep deprivation in patients with endocrine metabolic disorders

In 2014, Saxenda was the first GLP-1 introduced specifically for chronic weight management, followed by Wegovy in 2021 and Zepbound in 2023

Protein-rich foods are filling and slow to digest

At the same time, they act on appetite centers in the brain to reduce hunger and cravings, and they slow stomach emptying so people feel full sooner and stay satisfied longer

The study authors said they hope their findings prompt regulatory agencies and drug manufacturers to update warning labels for the medication and include gastroparesis as a potential side effect